FASMAC
FASMAC is a Japanese biotechnology company providing custom DNA/RNA synthesis, Sanger and next-generation sequencing, CRISPR genome editing tools, and ISO/IEC 17025-accredited food, seed, and plant-pathology testing services to food manufacturers, life science researchers, and seed/agricultural companies primarily in Japan.
- Company typePrivate
- Founded2001
- HeadquartersAtsugi, Japan
- Headcount11–50
- GTM typeB2B
- OfferingServices
What FASMAC does
FASMAC Co., Ltd. (株式会社ファスマック) is a Japanese biotechnology company founded in 2001 and headquartered in Atsugi, Japan, providing contract molecular biology services and food safety testing. The company operates a vertically integrated service platform spanning custom oligonucleotide and gene synthesis, PNA synthesis, Sanger capillary sequencing, next-generation sequencing (via both Illumina and MGI DNB-SEQ platforms), CRISPR/Cas-based genome editing tools, and a proprietary random integration analysis method called RAISING. On the testing side, FASMAC offers food inspection (GMO, allergen, microbial, mycotoxin, and variety identification), seed and seedling testing under ISTA accreditation, plant pathology diagnostics, and veterinary diagnostics, all delivered through an ISO/IEC 17025-accredited testing laboratory operating under an ISO9001-certified quality management system.
FASMAC's technology stack combines in-house developed proprietary assets with licensed IP. The patented RAISING method, co-developed with Japan's National Institute of Infectious Diseases and published in Communications Biology, enables identification of random transgene integration sites with high sensitivity, short turnaround, and lower cost than conventional approaches. The company holds an ERS Genomics-licensed CRISPR/Cas patent portfolio (Patents 6343605 and 6692856) covering Japan and operates the GenomeCraft sub-brand for sgRNA, crRNA/tracrRNA, Cas9 protein, and donor DNA. In-house reagent kit brands include GenCheck (DNA extraction and qPCR reagents), FLight (LAMP isothermal amplification detection), FASPEK (ELISA allergen detection), and AGripalette (plant pathogen detection). Quality and accreditation infrastructure — ISO9001, ISO/IEC 17025, and ISTA — underwrite the regulatory credibility of testing services.
Commercially, FASMAC generates revenue through commissioned service fees (e.g., RAISING Sanger sequencing at 120,000 JPY per 8 samples; NGS at 250,000 JPY per 8 samples), reagent kit sales, and licensing-related distribution. Distribution combines a self-serve web ordering platform (Fasmac Web System) with a regional distributor/agency network across Japanese prefectures. Customers span three primary verticals: food industry companies requiring safety and labeling compliance, life science research institutions and biotech firms needing custom oligos, sequencing, and genome editing tools, and seed and agricultural companies requiring ISTA-certified seed testing and plant pathology diagnostics. The company has a minority-held food testing subsidiary in Qingdao, China, and an affiliated Asia Food Safety Research Center, and has announced a planned facility relocation for spring 2027 or later to support continued expansion. No revenue, funding, or headcount-growth data is publicly disclosed.
FASMAC firmographics
Firmographics- Name
- FASMAC
- Legal name
- 株式会社ファスマック
- Website
- https://fasmac.co.jp
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FASMAC is a Japanese biotechnology company providing custom DNA/RNA synthesis, Sanger and next-generation sequencing, CRISPR genome editing tools, and ISO/IEC 17025-accredited food, seed, and plant-pathology testing services to food manufacturers, life science researchers, and seed/agricultural companies primarily in Japan.
- Ownership category
- akta.pro rank
FASMAC industry classification
Industry- Product category
- Biotechnology Contract Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Environmental Monitoring Program (EMP) Design & Regulatory Verification (AFALADAI)
- akta.pro secondary industries
- Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Import/Export Traceability & Trade Compliance Verification (FSMA, EU TRACES) (AFALAGAI)
Keywords
Where FASMAC is headquartered
LocationHeadquarters
- HQ city
- Atsugi
- HQ country
- Japan
- HQ region
- Asia
Markets served
FASMAC business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | RAISING Sanger Sequencing Plan — 8 samples, 5-10 business days |
| Unit Pricing | Pay-as-you-go | RAISING NGS Plan — 8 samples, 20 business days |
Distribution channels4 records
FASMAC product offering
Product offeringCore offering
FASMAC provides custom DNA/RNA and artificial gene synthesis, Sanger and next-generation sequencing, CRISPR/Cas genome editing tools (GenomeCraft), and the proprietary RAISING random integration analysis method. It also runs ISO/IEC 17025 accredited contract testing for food safety (GMO, allergen, microbial, mycotoxin), seed/seedling pathology, and plant disease, and sells proprietary reagent kits under the GenCheck, FLight, FASPEK, and AgriPalette brands.
Product overview
FASMAC is a Japanese biotech company offering a comprehensive portfolio of contract synthesis, sequencing, and testing services. The core offerings include artificial gene synthesis, DNA/RNA custom synthesis (including primers, modified oligos, and PNA), DNA sequencing (Sanger capillary sequencing), next-generation sequencing (NGS), and genome editing tools (GenomeCraft including CRISPR guide RNA, Cas9, donor DNA). The company also provides specialized analytical services including the proprietary RAISING random integration analysis method, fragment analysis, and genotyping. On the testing side, FASMAC offers food inspection services (GMO testing, allergen testing, microorganism identification), seed/seedling inspection, and plant pathology testing. The company sells reagent kits under the GenCheck brand for DNA extraction and PCR, along with LAMP method products (FLight series), allergen detection kits, and microorganism detection kits. Services are manufactured under ISO9001 quality standards and ISO/IEC 17025 accredited testing laboratory standards.
Differentiator
Problem solved
Functional benefit
Brands
- GenCheck: DNA extraction and PCR kits brand
- GenomeCraft
- FLight
- FASPEK
- AGripalette
Products and services
- Artificial Gene Synthesis (人工遺伝子合成)
- DNA/RNA Custom Synthesis (DNA/RNA受託合成)
- PNA Synthesis (PNA合成)
- DNA Sequencing Analysis (DNAシーケンス解析)
- Next Generation Sequencing Analysis (NGS)
- Fragment Analysis (フラグメント解析)
- GenomeCraft Genome Editing Tools (GenomeCraft ゲノム編集ツール)
- RAISING Random Integration Analysis (RAISING)
Quantifiable outcome
- Next-day delivery available for standard primer orders
- +3 more outcomes
Companies that use FASMAC
Customer profileSegments3 records
Ideal customer profiles3 records
FASMAC technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
FASMAC partnerships and signals
Strategic signalRecent moves7 records
Expansion highlights5 records
FASMAC competitors and assessment
Company assessmentDirect peers
- Hokkaido System Science: Japanese contract research organization providing DNA sequencing, custom synthesis, and molecular biology services to academic and industrial customers in Japan. Highly comparable as a domestic Japan-based molecular biology CRO with overlapping service portfolio and similar customer base.
- Macrogen: Korean genomics services company offering DNA sequencing, gene synthesis, oligo synthesis, and molecular biology services across Asia. Comparable in service mix (sequencing, synthesis, genotyping) and Asian market focus, with similar customer segments in academic and biotech research.
- BGI Genomics / MGI Tech: Chinese genomics company providing DNA sequencing (including the DNB-SEQ platform that FASMAC uses), gene synthesis, and molecular biology services globally. Comparable in sequencing services and Asian market presence, with similar food testing and agricultural genomics offerings.
- GenScript: Global gene synthesis, peptide, and protein services company with strong Asia presence. Comparable in gene synthesis, oligo services, and life science research tools for biotech customers, with overlapping CRISPR-related offerings.
- Azenta Life Sciences (formerly GeneWiz): Genomics services company providing Sanger sequencing, NGS, gene synthesis, and molecular biology services to academic and biotech customers. Comparable in core genomics services, customer segments, and turnaround-driven service model.
- Twist Bioscience: DNA synthesis company offering custom genes, oligos, and NGS target enrichment at scale using a silicon-based synthesis platform. Comparable in DNA synthesis and gene synthesis services, though at much larger scale and with different underlying synthesis technology.
- Nippon Genetics: Japan-based distributor and supplier of molecular biology reagents, enzymes, and instruments to research customers. Comparable as a Japan-headquartered life science tools provider serving the same academic and biotech research customer base.
- Eurofins GeneScan: Specialized food testing laboratory under Eurofins focused on GMO detection, allergen testing, and food authenticity. Directly comparable to FASMAC's food inspection services including GMO and allergen testing, though operating at much larger global scale.
Broad incumbents
- Eurofins Genomics: Global genomics services arm of Eurofins Scientific, offering DNA synthesis, Sanger and NGS sequencing, and genotyping services at industrial scale. Comparable in core service offerings but operates at significantly larger scale with global distribution and broader catalog.
- IDT (Integrated DNA Technologies): Global leader in DNA/RNA oligonucleotide synthesis and genomics services, now part of Danaher. Comparable in custom oligo synthesis and NGS services but operates at much larger scale with global distribution and broader modified-nucleotide catalog.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
FASMAC social profiles
Digital presenceFASMAC compliance and trust
Trust signalCompliance2 records
FASMAC financial estimates
Financial estimateRevenue estimate
Valuation estimate
FASMAC leadership team
Management profileNumber of profiles
Profiles2 records
FASMAC subsidiaries and ownership
Company hierarchySubsidiaries2 records
FASMAC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FASMAC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FASMAC
What does FASMAC do?
FASMAC provides custom DNA/RNA and artificial gene synthesis, Sanger and next-generation sequencing, CRISPR/Cas genome editing tools (GenomeCraft), and the proprietary RAISING random integration analysis method. It also runs ISO/IEC 17025 accredited contract testing for food safety (GMO, allergen, microbial, mycotoxin), seed/seedling pathology, and plant disease, and sells proprietary reagent kits under the GenCheck, FLight, FASPEK, and AgriPalette brands.
Is FASMAC a public or private company?
FASMAC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was FASMAC founded?
FASMAC was founded in 2001. It employs 11 to 50 people.
Where is FASMAC based?
FASMAC is headquartered in Atsugi, Japan, in the Asia region.
Who are FASMAC's main competitors?
Direct peers on record are Hokkaido System Science, Macrogen, BGI Genomics / MGI Tech, GenScript, Azenta Life Sciences (formerly GeneWiz), Twist Bioscience, Nippon Genetics and Eurofins GeneScan. Broad incumbents are Eurofins Genomics and IDT (Integrated DNA Technologies).
Does FASMAC have an API?
No public API is recorded for FASMAC.
What industry is FASMAC in?
FASMAC's product category is Biotechnology Contract Services. Its primary akta.pro industry code is AFALADAI, Environmental Monitoring Program (EMP) Design & Regulatory Verification, with a secondary code of AFAEAJAC, Genomic Testing & Genetic Evaluation Services. Its NAICS code is 5417 and its SIC code is 8734.